The Global report on “Isoflavones Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report also details the information about the global market status, growth rate, future trends, market drivers, challenges, opportunities and porter’s forces analysis with respect to these elements. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2670296
“The isoflavones market is projected to grow at a CAGR of 4.7%, in terms of value.”
The global isoflavones market is estimated to be valued at USD 1.1 billion in 2019 and is likely to reach USD 1.5 billion by 2025, growing at a CAGR of 4.7% during the forecast period. Isoflavones are a phytoestrogen produced mainly by plants of the legume family, namely, soybeans, chickpeas, and red clover. They are potentially useful in lowering cholesterol, treating cancers and menopausal symptoms, maintain bone health, and so on. Growth in this market is mainly driven by the increasing incidences of chronic diseases, rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population. However, stringent regulatory requirements and unfavorable drug price control policies across various countries are significant factors that are expected to restrain the growth of this market to a certain extent.
“The soy segment in isoflavones market is estimated to account for the largest share in 2019.”
Based on the source, the soy segment is estimated to account for the largest share in the isoflavones market in 2019. The segment is growing owing to factors such as nutritional and functional health-related properties since soy isoflavones are derived from soybeans and are particularly prevalent in soy germ. Genistein and daidzein are the major isoflavones present in soybean, which help in promoting overall health and wellness.
“The pharmaceuticals segmentin the isoflavones market is estimated to account for the largest share in 2019.”
Based on the application, pharmaceuticals are estimated to account for the largest market share. The factors behind the growth is increasing the prevalence of diseases such as cancer, osteoporosis, and arthritis fuels the demand for isoflavones as they reduce the risk of the above-mentioned diseases and provide therapeutic effects.
“The North American isoflavones market is projected to witness significant growth.”
The North America region is projected to hold the major market share in the isoflavones market. It includes the US, Canada, Mexico. According to the United States Department of Agriculture, the US produced 341.62 million metric tons of soybean, Canada produced 7.72 million metric tons, and Mexico 0.43 million metric tons, in the year 2017–2018. The region is one of the leading producers of soybeans, which creates ample opportunities for the manufacturing of isoflavones. Another factor propelling the growth of isoflavones in the region is rising obesity, which is a major concern among the youth, which is directing consumer focus toward a healthy lifestyle, thereby promoting their overall health and wellness.
Break-up of Primaries:
- By Company Type: Tier 1 – 45%, Tier 2 – 33%,and Tier 3 – 22%
- By Designation: C-level – 70%, Director-level – 20%, and Others*– 10%
- By Region: North America –40%, Europe- 30%, Asia Pacific – 20%, and RoW**–10%,
*Others include sales managers, marketing managers, and product managers.
**RoW includes South America and the Middle East & Africa.
Leading players profiled in this report:
This report includes a study of marketing and development strategies along with the product portfolios of the leading companies in the isoflavones market. It consists of the profiles of leading companies such as Cargill (Germany), ADM (US), BASF (Germany), DSM (Netherlands), International Flavors and Fragrances (Frutarom) (US), Shanghai Freemen (US), Nexira Inc. (France), Bio-gen Extracts, Sikko Industries, SK Bioland (South Korea), BioMax (India), Avestia Pharma (India), Nutra Science Labs (US), Tradichem S.L. (Spain), Nutra Green Biotechnology (China), HerboNutra (India), FutureCeuticals Inc. (US), Bio-gen Extracts (US), Xena Bio Herbals Pvt. Ltd. (India), Sikko Industries (India), Biomax (India), and Lactonova (India).
The report segments the isoflavones market based on source, application, form, and region. In terms of insights, this report has focused on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss views on the emerging & high-growth segments of the global isoflavones high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
- To get a comprehensive overview of the isoflavones market.
- To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them.
- To gain insights about the major countries/regions, in which the isoflavones market is gaining popularity.
More information about Discount offers (20% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=2670296
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441